The abstract is read at the publisher; the summary is JClub's.
Patients in dermatology studies (20 included) show conditional support for AI, but consistently prefer dermatologist-supervised AI over autonomous AI, especially for high-stakes diagnosis.
- Why it matters: Trust in dermatology AI is not well characterized, limiting safe adoption in patient-facing workflows like diagnosis, screening, and teledermatology support.
- What they did: A PRISMA-guided systematic narrative review synthesized empirical studies (January 1, 2015 through July 7, 2026) using interviews, surveys, vignette or conjoint experiments, and early deployments.
- The result: Trust increases with clinician accountability, clear explanations of outputs and uncertainty, privacy safeguards, transparent data use, and reliable performance across skin tone and diagnosis; it declines with clinician-replacement framing or unclear image governance.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.